Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma: Incidence, Predictors, and Prognostic Impact.

ABSTRACT:

Background

Atrial fibrillation (AF) is a common and clinically significant complication in cancer patients, but data on its incidence and impact among multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT) remain limited.

Objectives

The aim of this study was to characterize the incidence, predictors, and prognostic implications of AF following ASCT in MM patients.

Methods

A total of 801 MM patients who underwent ASCT between 2016 and 2022 were retrospectively analyzed. Pretransplantation evaluation included electrocardiography and echocardiography within 180 days of conditioning. Patients with AF at baseline were excluded. Post-transplantation AF was defined as electrocardiography-confirmed AF occurring after stem cell infusion.

Resul

SUBMITTER: Bolaji O 

PROVIDER: S-EPMC12922618 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature